No ETFs Required: How a 64-Year-Old Built a $5,700 Monthly Paycheck From Five Dividend Stocks
Most retirees assume hitting a $68,400 annual income floor demands either a massive nest egg or risky high-yield instruments, but five ordinary dividend stocks across five sectors challenge both assumptions in ways the math makes hard to ignore.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
A $5,700 monthly paycheck works out to $68,400 a year, roughly what a comfortable retirement runs for a debt-free 64-year-old in most of the country. The goal here is to hit that number using five individual dividend stocks, one per sector, all paying qualified dividends. No covered call ETFs, no BDCs, no monthly-pay closed-end funds.
The five-stock blueprint is straightforward: Verizon (NYSE:VZ | VZ Price Prediction) for telecom, Chevron (NYSE:CVX) for energy, AbbVie (NYSE:ABBV) for pharma, Philip Morris International (NYSE:PM) for tobacco and smoke-free, and Southern Company (NYSE:SO) for regulated utilities. Equal 20% weights across the five.
Where the Yields Actually Sit Today
At current prices, the forward yields shake out like this. The telecom name pays about 5.6% on a $2.83 annualized payout. The energy major yields roughly 3.4% on $7.12. The pharmaceutical company sits near 2.7% of $6.92. The tobacco giant comes in around 3.1% on $5.88. And the utility pays about 3.5% on $3.04. If you weight them equally, the basket lands at a blended yield near 3.7%. To generate $68,400 of income at that average, you need roughly $1.87 million in capital, split $374,000 across each of the five positions.
That is a meaningful sum, no question. But it is still less than what a Treasury-only strategy would require at the current 4.75% yield on the 10-year, once you factor in what these companies do that Treasuries do not. They raise the payout over time.
Three Ways to Size the Portfolio
The core math is $68,400 divided by yield. Three tiers illustrate the tradeoff:
- Conservative tier (3% to 4%): Run the math at 3.5%, and $68,400 a year requires $1,954,000 in capital. That is where the five-stock basket lands if you lean heavier into the energy major, the pharmaceutical company, and the utility. You are putting up the most money upfront, but the principal keeps compounding over time. The drug company’s quarterly payout has climbed from $1.07 in 2019 to $1.73 in 2026, and the oil giant has gone from $1.29 in 2020 to $1.78 in 2026. That is sleep-at-night income that actually grows.
- Moderate tier (5% to 7%): At a 5.5% yield, that same $68,400 annual target calls for $1,244,000. You get there by overweighting the telecom name and mixing in preferred shares, REITs, or high-dividend equity funds. The telecom company just marked its 20th consecutive year of dividend increases, though the latest raise was only 2.5%. Payout growth has flattened, and total return leans more on the coupon than on price appreciation.
- Aggressive tier (8% to 14%): $68,400 divided by 0.10 equals $684,000. Leveraged covered call funds, mortgage REITs, and high-yield bond funds live here. Distributions frequently get cut, and the principal often erodes. You are spending the asset, not living off its growth.
Why the Lower Yield Often Wins
A 3.7% yield that grows 6% to 8% annually doubles your income in roughly nine to twelve years. A 10% yield with a flat or shrinking payout stays put or slides. In this basket, Chevron has raised its dividend for more than two decades, Southern’s quarterly payout has ticked up from $0.56 in 2017 to $0.76 today, and Philip Morris has moved from $1.00 per quarter in 2015 to $1.47 in 2026.
That growth is why AbbVie is up 512% over 10 years, and Chevron is up 219%, with the yield reinvested along the way. The whole point of a ladder like this is never having to sell a share to pay a bill, and we walked through how to build one in a free guide here.
The catch: concentration. Five stocks in five sectors are diversified relative to owning one, but a Humira-style patent cliff, an oil-price collapse, or an FDA action on nicotine pouches can each hit 20% of the income stream at once. AbbVie’s $10.9 billion Apogee acquisition and 14-cent EPS dilution illustrate the reinvestment risk baked into the pharma slot.
Three Steps to Take This Week
- Price out your real number. Pull last year’s actual spending, not your pre-retirement salary. If you can live on $54,000, your capital target drops by roughly $400,000 at a 3.7% blended yield.
- Stress-test the growth assumption. Model each holding at half its recent five-year dividend growth rate. If the math still works, the plan is durable. If it does not, add a sixth or seventh position rather than reach for yield.
- Run the tax layer. All five names pay qualified dividends, taxed at 0%, 15%, or 20% federally depending on the bracket. In a state like California or New York, layer state tax on top before deciding how much of the portfolio belongs in a taxable account versus an IRA.
Contact [email protected] for any questions or corrections.
David Beren has been a Flywheel Publishing contributor since 2022. Writing for 24/7 Wall St. since 2023, David loves to write about topics of all shapes and sizes. As a technology expert, David focuses heavily on consumer electronics brands, automobiles, and general technology. He has previously written for LifeWire, formerly About.com. As a part-time freelance writer, David’s “day job” has been working on and leading social media for multiple Fortune 100 brands. David loves the flexibility of this field and its ability to reach customers exactly where they like to spend their time. Additionally, David previously published his own blog, TmoNews.com, which reached 3 million readers in its first year. In addition to freelance and social media work, David loves to spend time with his family and children and relive the glory days of video game consoles by playing any retro game console he can get his hands on.
